RICT 2017
Conferences > Upcoming events > RICT 2017

Confirmed Speakers


Plenary Speakers

Dr Jean-Philippe ANNEREAU
Dr Jean-Philippe ANNEREAU
ALEXION, Paris, France
Read more

Partnering Early to Better Serve Patients Suffering from Rare and Devastating Diseases

Dr Bernard BARLAAM
Dr Bernard BARLAAM
ASTRAZENECA, Macclesfield, United Kingdom
Read more

Identifying High Quality, Potent and Selective Inhibitors of ATM Kinase for Oncology Therapies: Discovery of AZD0156

Prof. Annette BECK-SICKINGER
Prof. Annette BECK-SICKINGER
LEIPZIG UNIVERSITY, Leipzig, Germany
Read more

Peptide Drugs to Target GPCR- State of the Art and Innovative Application

Dr Stefano CROSIGNANI
Dr Stefano CROSIGNANI
ITEOS THERAPEUTICS SA, Gosselies, Belgium
Read more

Discovery of PF-06840003, a Novel IDO Inhibitor for Cancer Immunotherapy

Prof. Ben DAVIS
Prof. Ben DAVIS
OXFORD UNIVERSITY, Oxford, United Kingdom
Read more

Sugars and Proteins

Prof. Piet HERDEWIJN
Prof. Piet HERDEWIJN
KU LEUVEN, Leuven, Belgium
Read more

Xeno Nucleic Acids (XNA) in vivo : A New Medicinal Chemistry Approach?

Prof. Tad HOLAK
Prof. Tad HOLAK
MAX PLANCK INSTITUTE OF BIOCHEMISTRY, Martinsried, Germany
Read more

Monitoring the Antagonist-Protein and Protein-Protein Interactions with NMR and X-ray: Inhibitors of the p53-Mdm2 and Immune Checkpoint PD-1/PD-L1 Interactions

Dr Ignace LASTERS
Dr Ignace LASTERS
COMPLIX, Zwijnaarde, Belgium
Read more

Engineering Alphabodies to Generate Potent Druggable Inhibitors of Intracellular Protein-Protein Interactions

Prof. Stefan LAUFER
Prof. Stefan LAUFER
UNIVERSITY TÜBINGEN, Tübingen, Germany
Read more

Raising the Gold Standard: Design & Development of Highly Selective JAK3 Probes (Janus Kinase 3)

Dr Nicolas MEYER
Dr Nicolas MEYER
ONCOPOLE TOULOUSE, Toulouse, France

Title of talk to be confirmed

Dr Ronan O'HAGAN
Dr Ronan O'HAGAN
MERCK, SHARP & DOHME, Boston, United States
Read more

Small Molecule Approaches in Immune-Oncology

Prof. Romano ORRU
Prof. Romano ORRU
VU UNIVERSITY AMSTERDAM, Amsterdam, The Netherlands

Read more

One-pot Cascade Syntheses Using Multicomponent Reactions and Biocatalysis

Prof. Didier ROGNAN
Prof. Didier ROGNAN
UNIVERSITY OF STRASBOURG, Illkirch, France
Read more

First-in-class Extracellular Modulators of Receptor Tyrosine Kinases: from Theory to Practice

Prof. Tanja SCHIRMEISTER
Prof. Tanja SCHIRMEISTER
UNIVERSITY OF MAINZ, Mainz, Germany
Read more

Allosteric Inhibitors of Dengue and Zika Virus NS3/NS2B Proteases

Prof. Gisbert SCHNEIDER
Prof. Gisbert SCHNEIDER
ETH ZÜRICH, Zürich, Switzerland
Read more

De Novo Drug Design — Inspiration from Nature

Dr Hong SHEN
Dr Hong SHEN
F. HOFFMANN-LA ROCHE, Shanghai, China
Read more

Structure-based Drug Design (SBDD) in Medicinal Chemistry-enabled Drug Discovery

Dr Nicolas SOLDERMANN
Dr Nicolas SOLDERMANN
NOVARTIS, Basel, Switzerland
Read more

Discovery of Leniolisib, a Novel and Selective PI3Kδ Inhibitor for Autoimmune and Inflammatory Diseases

Prof. Roderich D. SÜSSMUTH
Prof. Roderich D. SÜSSMUTH
TECHNICAL UNIVERSITY BERLIN, Berlin, Germany
Read more

Bioactive Ribosomal and Non-Ribosomal Peptides from Nature - Structures, Biosynthesis and Engineering Options

Dr Frédéric TARAN
Dr Frédéric TARAN
CEA/SACLAY, Gif-sur-Yvette, France
Read more

Chemoselective and Biocompatible Reactions, New Tools for Heterocyclic Chemistry and Chemical Biology

Dr Heather TYE
Dr Heather TYE
EVOTEC (UK) LTD, Abingdon, United Kingdom
Read more

Development of Dual IGF1R/INSR Inhibitors a Case Study

Prof. Xiaodong WANG
Prof. Xiaodong WANG
UNIVERSITY OF NORTH CAROLINA, Chapel Hill, United States
Read more

Novel Small Molecule MerTK Inhibitors and their Biological Uses

Keynote Speakers

Dr Eric DORIS
Dr Eric DORIS
CEA, Gif-sur-Yvette, France
Read more

Nanometric Micelles for in vivo Imaging and Drug Delivery

Prof. Mélanie ETHEVE-QUELQUEJEU
Prof. Mélanie ETHEVE-QUELQUEJEU
UNIVERSITÉ PARIS DESCARTES, Paris, France
Read more

Post-functionalization of RNAs for Specific Conjugations with Peptides and Proteins

Dr Christelle HUREAU
Dr Christelle HUREAU
LABORATOIRE DE CHIMIE DE COORDINATION UPR 8241, Toulouse, France
Read more

Impact of Zinc in Therapeutic Approaches to Fight Alzheimer’s Disease

Dr Aurelie MALLINGER
Dr Aurelie MALLINGER
INSTITUTE OF CANCER RESEARCH, Sutton, London, United Kingdom
Read more

Discovery of CDK8/CDK19 Kinase Modulators and Evaluation of their Therapeutic Potential

Dr Kassoum NACRO
Dr Kassoum NACRO
EXPERIMENTAL THERAPEUTICS CENTER, Singapore, Singapore
Read more

Discovery of Mnk1/2 Kinases Inhibitors for the Treatment of Leukaemia

Dr Gilles OUVRY
Dr Gilles OUVRY
GALDERMA R&D, SOPHIA ANTIPOLIS, France
Read more

Discovery of Novel TACE Inhibitors for Topical Treatment of Psoriasis

Dr Vincent RODESCHINI
Dr Vincent RODESCHINI
EDELRIS, LYON, France
Read more

Mining from NP-Like Fragments in 3D: Discovery of a Potent Caspase-1 Inhibitor

Dr Eric VALEUR
Dr Eric VALEUR
ASTRAZENECA, Västra Frölunda, Sweden
Read more

Accessing New Chemical Space to Address Challenging Target Classes: from Genetic Encoding of Cyclic Peptides to Hybrid Macrocycles


Organised by

EFMC Sponsored Event

ESOF Labelised Event

Media Partner

Copyright 2017 LD Organisation  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 10 454777  |   |  VAT: BE 0464819842
Developed and powered by Antalys